|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
N/A
|
National Institutes of Health
|
|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Investigating the cell of origin for bladder cancer
|
5R01CA193442-04
|
$474,774
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Development of personalized surgical algorithms for muscle-invasive bladder cancer patients
|
5R21CA218976-02
|
$238,815
|
ABBOSH, PHILIP
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$185,015
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$30,836
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Investigation of Epigenetic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$154,179
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Targeting Metabolic Pathways in Bladder Cancer
|
ZIA BC 011741
|
$154,179
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$30,836
|
Agarwal, Piyush
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$61,672
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-04S1
|
$145,357
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-05
|
$922,200
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
ATBC Study
|
ZIA CP010195 03031
|
$738,165
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation
|
5R01CA201561-03
|
$377,438
|
AN, WOOJIN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$331,774
|
Apolo, Andrea
|
CCR (NCI)
|
|
Targeting the MET pathway in urothelial carcinoma
|
ZIA BC 011594
|
$497,661
|
Apolo, Andrea
|
CCR (NCI)
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-05
|
$605,293
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles
|
1R43CA232778-01
|
$295,240
|
ASSOULINE, JOE
|
NANOMEDTRIX, LLC
|
|
IGF::OT::IGF TOPICAL EGCG (VEREGEN) IN CERVICAL DYSPLASIA, A FEASIBILITY CLINICAL TRIAL
|
261201200033I
|
$1,922,742
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
SPORE in Bladder Cancer
|
1P50CA221745-01A1
|
$2,299,837
|
BAJORIN, DEAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$314,516
|
Barchi, Joseph
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
Barr, Frederic
|
CCR (NCI)
|
|
Proliferation and Differentiation of Bladder Epithelial Cells in Regeneration and Malignancy
|
2R01CA157877-06A1
|
$507,988
|
BEACHY, PHILIP
|
STANFORD UNIVERSITY
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 02020
|
$592,688
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Disinfection Biomarker
|
ZIA CP010120 02093
|
$21,144
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S1
|
$3,249,644
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$330,596
|
Beutler, John
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$3,561,926
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Hsp90B in Bladder Cancer
|
1R01CA222894-01
|
$365,328
|
BLAGG, BRIAN
|
UNIVERSITY OF NOTRE DAME
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-05S1
|
$670,913
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-05
|
$8,625,592
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$396,445
|
Bottaro, Donald
|
CCR (NCI)
|
|
Leukocyte telomere length in bladder cancer survivors: Diet and exercise trial
|
5R21CA212628-02
|
$203,580
|
BOVBJERG, DANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
5U10CA180844-05
|
$898,424
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Molecular biology of human polyomaviruses
|
ZIA BC 011090
|
$387,112
|
Buck, Christopher
|
CCR (NCI)
|
|
Mass Spectrometry Detection of Drugs in Single Bladder Cancer Cells from Patients
|
5R21CA204706-03
|
$40,682
|
BURGETT, ANTHONY
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-05
|
$1,302,199
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine
|
5U01CA217858-02
|
$1,314,469
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Pharmacogenetics
|
ZIA CP005804 08260
|
$34,139
|
Caporaso, Neil
|
DCEG (NCI)
|
|
NCTN Lead Academic Participating Sites Application
|
5U10CA180838-05
|
$623,046
|
CAREY, LISA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|